AAPL   324.89 (+0.48%)
MSFT   185.01 (+0.05%)
FB   230.19 (-1.09%)
GOOGL   1,438.83 (-0.24%)
AMZN   2,476.14 (+0.15%)
CGC   16.71 (+3.53%)
BABA   217.19 (+1.33%)
MU   49.06 (+4.78%)
GE   7.32 (+3.83%)
TSLA   880.90 (-0.07%)
AMD   52.52 (-1.91%)
T   31.55 (+1.81%)
F   6.21 (+5.08%)
GILD   74.26 (+1.37%)
NFLX   423.24 (-0.95%)
BAC   25.99 (+4.63%)
BA   172.23 (+12.34%)
AAPL   324.89 (+0.48%)
MSFT   185.01 (+0.05%)
FB   230.19 (-1.09%)
GOOGL   1,438.83 (-0.24%)
AMZN   2,476.14 (+0.15%)
CGC   16.71 (+3.53%)
BABA   217.19 (+1.33%)
MU   49.06 (+4.78%)
GE   7.32 (+3.83%)
TSLA   880.90 (-0.07%)
AMD   52.52 (-1.91%)
T   31.55 (+1.81%)
F   6.21 (+5.08%)
GILD   74.26 (+1.37%)
NFLX   423.24 (-0.95%)
BAC   25.99 (+4.63%)
BA   172.23 (+12.34%)
AAPL   324.89 (+0.48%)
MSFT   185.01 (+0.05%)
FB   230.19 (-1.09%)
GOOGL   1,438.83 (-0.24%)
AMZN   2,476.14 (+0.15%)
CGC   16.71 (+3.53%)
BABA   217.19 (+1.33%)
MU   49.06 (+4.78%)
GE   7.32 (+3.83%)
TSLA   880.90 (-0.07%)
AMD   52.52 (-1.91%)
T   31.55 (+1.81%)
F   6.21 (+5.08%)
GILD   74.26 (+1.37%)
NFLX   423.24 (-0.95%)
BAC   25.99 (+4.63%)
BA   172.23 (+12.34%)
AAPL   324.89 (+0.48%)
MSFT   185.01 (+0.05%)
FB   230.19 (-1.09%)
GOOGL   1,438.83 (-0.24%)
AMZN   2,476.14 (+0.15%)
CGC   16.71 (+3.53%)
BABA   217.19 (+1.33%)
MU   49.06 (+4.78%)
GE   7.32 (+3.83%)
TSLA   880.90 (-0.07%)
AMD   52.52 (-1.91%)
T   31.55 (+1.81%)
F   6.21 (+5.08%)
GILD   74.26 (+1.37%)
NFLX   423.24 (-0.95%)
BAC   25.99 (+4.63%)
BA   172.23 (+12.34%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Atossa GeneticsEndologixRA Medical SystemsNeovascTitan Medical
SymbolNASDAQ:ATOSNASDAQ:ELGXNYSE:RMEDNASDAQ:NVCNNASDAQ:TMDI
Price Information
Current Price$2.64$0.82$0.51$3.23$0.27
52 Week RangeBuyHoldHoldBuyBuy
Beat the Market™ Rank
Overall Score1.21.61.31.31.4
Analysis Score3.53.03.13.53.3
Community Score2.42.52.12.82.4
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.00.00.0
Earnings & Valuation Score0.01.31.30.01.3
Analyst Ratings
Consensus RecommendationBuyHoldHoldBuyBuy
Consensus Price Target$4.00$4.00$1.75$7.67$1.25
% Upside from Price Target51.52% upside387.80% upside242.47% upside137.36% upside362.96% upside
Trade Information
Market Cap$24.96 million$14.95 million$6.60 million$38.74 million$16.82 million
Beta2.590.721.222.752.93
Average Volume894,522387,9385,170,200120,8712,256,340
Sales & Book Value
Annual RevenueN/A$143.37 million$7.20 million$2.09 millionN/A
Price / SalesN/A0.110.9918.25N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.37 per share$3.56 per share$2.47 per share($1.46) per share($0.29) per share
Price / BookN/A0.230.21-2.21N/A
Profitability
Net Income$-17,240,000.00$-64,760,000.00$-56,960,000.00$-35,130,000.00$-41,910,000.00
EPSN/A($2.19)($4.33)($5.05)($1.95)
Trailing P/E RatioN/AN/AN/AN/A0.59
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-44.65%-732.37%-1,501.37%N/A
Return on Equity (ROE)-119.51%-63.96%-130.46%N/AN/A
Return on Assets (ROA)-104.79%-13.26%-101.56%-193.87%-195.16%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.29%0.10%N/AN/A
Current Ratio12.85%0.39%4.76%0.80%0.20%
Quick Ratio12.85%0.28%4.30%0.73%0.20%
Ownership Information
Institutional Ownership Percentage2.62%51.84%14.44%13.95%4.07%
Insider Ownership Percentage33.21%1.30%25.20%N/AN/A
Miscellaneous
Employees452895989
Shares Outstanding9.21 million19.17 million13.90 million11.81 million57.98 million
Next Earnings Date8/11/2020 (Estimated)8/13/2020 (Estimated)11/25/2020 (Estimated)8/5/2020 (Estimated)7/29/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.